Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne

Image 2-Seqirus’ Vaccine Manufacturing Facility
The facility will manufacture pandemic influenza vaccines, adjunct MF59® as well as antivenoms. Credit: Seqirus.